Skip to main content
. Author manuscript; available in PMC: 2008 Oct 29.
Published in final edited form as: Cancer Chemother Pharmacol. 2008 Mar 13;62(4):699–706. doi: 10.1007/s00280-008-0725-7

TABLE 1.

Western Blot-determined Relative Content of Bcl-2 and Caspase-3 and Tissue Culture-determined EC50 (NCS) for Seven Tumor Cell Lines

Cell Line Relative Bcl-2 Content Average (Experiment 1, Experiment 2) Relative Caspase-3 Content Average (Experiment 1, Experiment 2) EC50 (NCS) (nM) (n = 3)
SK-N-SH 82 (33, 132) 69 (69, 69) 19 ± 1
U87 53 (7, 99) 60 (47, 74) 29 ± 6
IMR-32 126 (99, 152) 75 (67, 82) 14 ± 1
SK-N-MC 106 (66, 147) 75 (83, 67) 11 ± 1
DAOY 71 (38, 105) 34 (1, 66) 53 ± 26
MCF-7 80 (66, 93) 0.1 (0.2, 0) 97 ± 28
BT474 62 (64, 60) 28 (9, 46) 83 ± 3